Skip to content

Clinical trials

Phase 3 Neurotoxicity Syndromes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurotoxicity Syndromes Phase: Phase 3 Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20051
20063
20073
20083
20094
20101
20111
20171
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting2
Enrolling by invitation1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology10
Gynecologic Oncology Group2
Eastern Cooperative Oncology Group1
Ellis Medicine1
Gary Morrow1
M.D. Anderson Cancer Center1
Murdoch Childrens Research Institute1
Northwestern University1
Radiation Therapy Oncology Group1
SWOG Cancer Research Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurotoxicity Syndromes22
Pain7
Peripheral Nervous System Diseases4
Brain Neoplasms3
Breast Neoplasms3
Colorectal Neoplasms3
Neoplasm Metastasis3
Colonic Neoplasms2
Fatigue2
Leukemia2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.